CEVA, Inc. — Q1 2017 Form 10-Q Summary
Business context and reporting period
CEVA licenses signal-processing intellectual property and related software to semiconductor and equipment manufacturers. Its technologies cover handset baseband, connectivity, audio, imaging, vision and deep learning applications. This unaudited filing covers the three months ended March 31, 2017, compared with Q1 2016; balance-sheet figures are compared with December 31, 2016. Unless stated otherwise, financial amounts below are in U.S. dollars.
Financial performance and position
| Metric | Q1 2017 | Q1 2016 / comparison |
|---|---|---|
| Revenue | $21.287 million | $16.508 million; up 29% |
| Licensing and related revenue | $9.535 million | $8.650 million; up 10% |
| Royalties | $11.752 million | $7.858 million; up 50% |
| Gross profit / margin | $19.591 million / 92% | $14.880 million / 90% |
| Operating income | $4.346 million | $1.822 million |
| Net income | $4.107 million | $1.800 million |
| Diluted earnings per share | $0.19 | $0.09 |
| Net cash from operating activities | $6.289 million | $0.236 million |
| Cash and cash equivalents at quarter-end | $12.621 million | $18.401 million at year-end 2016 |
| Cash, deposits and marketable securities | $163.6 million | $156.5 million at year-end 2016 |
Operating expenses were $15.245 million, versus $13.058 million. Net research and development expense rose to $9.873 million from $7.914 million. The filing reports no debt balance; liabilities shown include current liabilities of $22.556 million and long-term accrued severance of $8.875 million. Total current assets were $132.048 million, compared with current liabilities of $22.556 million.
Investing activities used $14.457 million, principally reflecting investment in bank deposits and marketable securities and $1.435 million of property and equipment purchases. Financing activities provided $2.363 million, including proceeds from stock-award exercises. CEVA made no share repurchases in Q1 2017.
Material changes versus the prior comparable period
- Revenue growth was driven chiefly by higher royalties, reflecting increased LTE baseband shipments following the 2016 holiday season. Customers reported 352 million chipsets incorporating CEVA technology, versus 230 million; non-handset baseband units were 76 million, versus 45 million.
- Licensing revenue reached a quarterly record. CEVA completed 11 licensing deals, all for non-handset baseband applications; four were with first-time customers.
- Operating income and net income increased substantially, while operating expenses also rose. Management attributed expense growth mainly to higher headcount and salaries, lower Israeli research grants, higher project costs and increased equity-based compensation.
- Cash from operations increased to $6.289 million from $0.236 million. The filing attributes the comparison partly to different working-capital movements between periods.
- Revenue mix shifted: handset baseband represented 56% of revenue versus 69% in Q1 2016; non-baseband DSP products represented 25% versus 21%; connectivity represented 19% versus 10%.
Outlook, management commentary and risks
Management expects available cash, deposits, marketable securities and operating cash flow to fund operations for at least the next 12 months, while cautioning that revenue and expense assumptions may not prove accurate. It gave no specific quarterly or full-year revenue or earnings guidance in the supplied filing text. Management described the licensing pipeline as progressing in line with expectations and highlighted opportunities in IoT, connectivity, vision processing, audio/voice and next-generation wireless. These are expectations and market opportunities, not assured results.
Key risks include revenue and royalty concentration, competitive and pricing pressure, dependence on handset baseband and customers’ product shipments, long and variable licensing cycles, and limited visibility into customer shipment timing. Five largest customers generated 63% of Q1 revenue; three customers represented 25%, 17% and 11%. Two royalty customers together generated 76% of royalty revenue. Other risks include foreign-exchange exposure, reliance on research grants and Israeli tax benefits, international operations, product-development execution and the cyclical semiconductor and consumer-electronics markets.
CEVA held $129.2 million of its $163.6 million in cash, deposits and securities through foreign subsidiaries and said it intended to permanently reinvest foreign earnings; repatriation could incur additional taxes. Marketable securities had $407,000 of gross unrealized losses at quarter-end, which management considered temporary; no impairment charge was recorded. Foreign-exchange hedging produced a $146,000 net gain in Q1. Management also noted that bank deposits exceed applicable insured limits, creating exposure if a financial institution fails.
The company adopted ASU 2016-09 on stock compensation in Q1, changing its forfeiture accounting to recognize forfeitures as they occur; management reported no material financial-statement impact. CEVA plans to adopt the new revenue-recognition standard on January 1, 2018 using the modified retrospective method and was still evaluating its effects. Management stated disclosure controls were effective at March 31, 2017 and reported no material litigation expected to affect the company.
Important facts for investors to verify
- Whether royalty growth and reported chipset shipments continue, and how much depends on a small number of customers and handset baseband.
- Whether the 11 non-baseband licensing deals convert into customer products, shipments and recurring royalties on expected timelines.
- How rising R&D spending, headcount and lower grant receipts affect future operating margins and product returns.
- The actual effects of the 2018 revenue-recognition adoption, including treatment of distinct deliverables and capitalization of contract acquisition costs.
- Liquidity available for U.S. operations after considering foreign-held funds, potential repatriation taxes, investment risks and possible acquisitions.
- Whether Israeli tax benefits and government grants remain available subject to their eligibility conditions.